Scarica l'app Stockscreener
1.92
2.54%
-0.05
Dopo l'orario di chiusura:
1.92
Precedente Chiudi:
$1.97
Aprire:
$1.96
Volume 24 ore:
714.53K
Relative Volume:
0.22
Capitalizzazione di mercato:
$51.04M
Reddito:
$155.00K
Utile/perdita netta:
$-30.01M
Rapporto P/E:
-1.1497
EPS:
-1.67
Flusso di cassa netto:
$-11.98M
1 W Prestazione:
-8.13%
1M Prestazione:
-32.75%
6M Prestazione:
-76.30%
1 anno Prestazione:
-68.78%
Intervallo 1D:
$1.89
$1.9867
Intervallo di 1 settimana:
$1.89
$2.09
Portata 52W:
$1.89
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Nome
Inmune Bio Inc
Settore
Industria
Telefono
(858) 964-3720
Indirizzo
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Confronta INMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.92 | 52.37M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-01 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-21 | Iniziato | Alliance Global Partners | Buy |
| 2024-09-27 | Iniziato | Raymond James | Outperform |
| 2024-08-22 | Iniziato | Scotiabank | Sector Outperform |
| 2023-06-01 | Iniziato | Robert W. Baird | Outperform |
| 2022-05-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
| 2021-04-21 | Iniziato | B. Riley Securities | Buy |
| 2021-01-22 | Reiterato | Maxim Group | Buy |
| 2020-09-01 | Iniziato | BTIG Research | Buy |
| 2020-07-15 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Inmune Bio Inc Borsa (INMB) Ultime notizie
Is INmune Bio Inc. forming a double bottomStock Surge & Weekly Return Optimization Plans - khodrobank.com
Real time social sentiment graph for INmune Bio Inc.July 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
What momentum shifts mean for INmune Bio Inc.2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
INmune Bio Inc.’s volatility index tracking explained2025 Market Overview & Low Drawdown Momentum Ideas - Newser
Is INmune Bio Inc. stock reversal real or fake2025 Market WrapUp & Community Trade Idea Sharing - Newser
Is INmune Bio Inc. still worth holding after the dipWeekly Trend Summary & Long Hold Capital Preservation Tips - Newser
Geopolitics Watch: Is INmune Bio Inc. showing insider buying2025 Macro Impact & Weekly Market Pulse Updates - khodrobank.com
Relative strength of INmune Bio Inc. in sector analysisWeekly Trade Recap & AI Based Buy/Sell Signal Reports - Newser
Technical signs of recovery in INmune Bio Inc.July 2025 Spike Watch & Verified Swing Trading Watchlist - Newser
What makes INmune Bio Inc. stock price move sharply2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
What’s next for INmune Bio Inc. stock pricePortfolio Profit Report & Fast Moving Stock Watchlists - Newser
What data driven models say about INmune Bio Inc.’s future2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Can INmune Bio Inc. recover in the next quarterJuly 2025 Market Mood & Real-Time Buy Signal Notifications - Newser
What to do if you’re stuck in INmune Bio Inc.Long Setup & Expert Verified Movement Alerts - Newser
Backtesting results for INmune Bio Inc. trading strategiesTrade Volume Summary & Low Volatility Stock Suggestions - Newser
Is INmune Bio Inc. stock bottoming out2025 Major Catalysts & Growth Focused Entry Reports - Newser
Analyzing INmune Bio Inc. with multi timeframe chartsJuly 2025 Closing Moves & Stepwise Trade Execution Plans - Newser
Tools to monitor INmune Bio Inc. recovery probability2025 Market Outlook & AI Forecast Swing Trade Picks - Newser
Evaluating INmune Bio Inc. with trendline analysisGDP Growth & Real-Time Buy Zone Alerts - Newser
Can swing trading help recover from INmune Bio Inc. lossesTrade Analysis Summary & Short-Term Trading Alerts - Newser
Is INmune Bio Inc. stock a value trapWeekly Gains Summary & Reliable Entry Point Alerts - khodrobank.com
Should I hold or sell INmune Bio Inc. now2025 Top Decliners & Stepwise Swing Trade Plans - khodrobank.com
Is INmune Bio Inc. impacted by rising ratesMarket Performance Report & High Conviction Buy Zone Alerts - khodrobank.com
Can INmune Bio Inc. hit a new high this month2025 Price Targets & Safe Entry Trade Signal Reports - Newser
What technical models suggest about INmune Bio Inc.’s comebackWeekly Market Outlook & AI Powered Trade Plan Recommendations - Newser
INmune Bio Inc. Trading Near Value Zone — Recovery Ahead getLinesFromResByArray error: size == 0 - kangso.co.kr
Will earnings trigger a reversal in INmune Bio Inc.July 2025 Market Mood & Breakout Confirmation Alerts - Newser
INmune Bio Inc. stock trend forecastEarnings Risk Summary & Daily Technical Forecast Reports - Newser
Can you recover from losses in INmune Bio Inc.Rate Hike & Safe Entry Point Alerts - Newser
News impact scoring models applied to INmune Bio Inc.Earnings Growth Report & Real-Time Volume Analysis - Newser
Is it too late to sell INmune Bio Inc.2025 Market Outlook & Smart Swing Trading Alerts - Newser
Will a bounce in INmune Bio Inc. offer an exit2025 Buyback Activity & Free Long-Term Investment Growth Plans - Newser
INmune Bio reverses early gains after stock offering - MSN
Inmune Bio Inc Azioni (INMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Inmune Bio Inc Azioni (INMB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tesi Raymond Joseph | President and CEO |
Sep 12 '24 |
Buy |
6.38 |
15,380 |
98,048 |
1,554,106 |
| Moss David J | Chief Financial Officer |
Sep 12 '24 |
Buy |
6.38 |
7,690 |
49,024 |
1,275,869 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):